D054328Chemicals & DrugsD27.505.519.389.8489100.989986Proton Pump InhibitorsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson23623526Lima JJ, Lang JE, Mougey EB, Blake KB, Gong Y, Holbrook JT, Wise RA, Teague WGThe Journal of pediatricsLima JJ, Lang JE, Mougey EB, Blake KB, Gong Y, Holbrook JT, Wise RA, Teague WG. Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children. J Pediatr. 2013 Sep; 163(3):686-91.J Pediatr2013-04-24T00:00:002013Association of CYP2C19 polymorphisms and lansoprazole-associated respiratory adverse effects in children.Wake Forest School of MedicineStephenWrightStephen C. Wright MD36.09179160000000-80.27248880000000119Wright, StephenAssociate ProfessorEmmanuelOparaEmmanuel C. Opara PhD36.08943500000000-80.26863200000000276Opara, EmmanuelProfessorRodolfoPascualRodolfo M. Pascual MD36.08959100000000-80.26859900000000836Pascual, RodolfoAssociate ProfessorStevenClaytonSteven B. Clayton MD36.09040200000000-80.267005999999992287Clayton, StevenAssociate Professor29763274Clayton S, Emerson JFAmerican family physicianClayton S, Emerson JF. Eosinophilic Esophagitis: A Mimic of Gastroesophageal Reflux Disease. Am Fam Physician. 2018 05 15; 97(10):628-629.Am Fam Physician2018-05-15T00:00:002018Eosinophilic Esophagitis: A Mimic of Gastroesophageal Reflux Disease.24Assistant Professor33189702Elmunzer BJ, Wolf BJ, Scheiman JM, Tierney WM, Taylor JRGastroenterologyElmunzer BJ, Wolf BJ, Scheiman JM, Tierney WM, Taylor JR. Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19. Gastroenterology. 2021 Mar; 160(4):1417-1422.e14.Gastroenterology2020-11-12T00:00:002020Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.Internal Medicine, GastroenterologyInternal Medicine, Pulmonary, Critical Care, Allergy and Immunologic DiseasesOtolaryngologyWake Forest Institute for Regenerative Medicinetrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor20144536Chapman DB, Rees CJ, Lippert D, Sataloff RT, Wright SCJournal of voice : official journal of the Voice FoundationChapman DB, Rees CJ, Lippert D, Sataloff RT, Wright SC. Adverse effects of long-term proton pump inhibitor use: a review for the otolaryngologist. J Voice. 2011 Mar; 25(2):236-40.J Voice2010-02-09T00:00:002010Adverse effects of long-term proton pump inhibitor use: a review for the otolaryngologist.RishiPawaRishi Pawa MBBS36.09023500000000-80.269246000000001653Pawa, RishiProfessor15350983Koch TR, Petro A, Darrabie M, Opara ECThe Journal of nutritional biochemistryKoch TR, Petro A, Darrabie M, Opara EC. Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice. J Nutr Biochem. 2004 Sep; 15(9):522-6.J Nutr Biochem2004-09-01T00:00:002004Effect of the H, K-ATPase inhibitor, esomeprazole magnesium, on gut total antioxidant capacity in mice.0.6625730.0230519research area of0.7957370.036321713subject area for